Bioworld Financial Watch articles from November 2005

Bioworld Financial Watch archives from November 2005

Supply worries, sick birds heat up flu vaccine world.(As Novartis Eyes More Buyouts)
November 7, 2005... Just as flu shot "clinics" started popping up in the Northern Hemisphere's grocery stores and pharmacies, Chiron Corp.--which last year embarrassed itself by botching half the U.S. supply of flu vaccine--took delivery of a new buyout proposal...

10 biggest U.S. gainers for the week.
November 7, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) VioQuest 70.59 Hana Bioscience 66.67 Human Genome Sci 62.75 Questcor Pharma 61.90 Pharsight 33.33 Abgenix ...

10 biggest U.S. losers for the week.
November 7, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) NABI -71.06 Hemispherx -61.25 MacroChem -40.00 VaxGen -37.25 Third Wave Tech -22.78 Xenogen ...

Public financing of biotechnology: October 2005.
November 7, 2005... Public Financing Of Biotechnology: October 2005 I. COMMENCED TRADING IN OCTOBER Company Date Date Shares/ Price Shares (Symbol) (#) Filed Comm. Units (M) Out ...

Other financings of public biotechnology companies: October 2005.
November 7, 2005... Other Financings Of Public Biotechnology Companies: October 2005 TOTAL: $266.25M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: October 2005.
November 7, 2005... Venture Capital And Corporate Investments In Biotechnology Companies: October 2005 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $588.75M Company Location Date Amt. (M) Aerie ...

Money raised by biotech in 2005: January-October.
November 7, 2005... Money Raised By Biotech In 2005: January-October Type of Jan. Feb. March April financing Public offerings 585.7 799.4 303.9 71.2 Private biotechs 406.3 636.6 276.4 182.4...

BioWorld stock report for public biotechnology companies.
November 7, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close WK YTD Vol 10/28 11/4 ...

Kos, Jerini deal for Icatibant heating HAE race to market.(Dyax Frontrunner?)
November 14, 2005... "First to market is generally a good place to be," said John Howarth, vice president of investor relations and corporate affairs for Kos Pharmaceuticals Inc., in a wry understatement last week. The occasion was Kos' entry into a race with...

10 biggest U.S. gainers for the week.
November 14, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Pain Therapeu 38.60 Gilead Sciences 4.40 Cepheid 32.22 New River 4.18 Simulations Plus 31.58 Biogen IDEC 2.93...

10 biggest U.S. losers for the week.
November 14, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Cellegy Pharma -32.04 Immucor -4.25 Novavax -22.45 Onyx Pharma -2.51 Large Scale -21.82 BioCryst -2.42 Access Pharma...

Clinical trials update: October 2005.
November 14, 2005... Clinical Trials Update: October 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Alba AT-1001 Oral zonulin receptor Therapeutics antagonist...

Non-U.S. clinical trials and regulatory actions: October 2005.
November 14, 2005... Non-U.S. Clinical Trials And Regulatory Actions: October 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Abbott Humira Adalimumab; fully human Laboratories ...

FDA submissions, approvals and other actions: October 2005.
November 14, 2005... FDA Submissions, Approvals And Other Actions: October 2005 Company * (Country; Symbol) Product Description AUTOIMMUNE Abbott Humira Adalimumab; fully human Laboratories (FDA-approved)...

BioWorld stock report for public biotechnology companies.
November 14, 2005... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 11/4 11/11 Aastrom Biosci ASTM 2.18 2.17 Abgenix ABGX 12.86 13.57...

Keryx's diabetic nephropathy compound standing in front.(CEO: 'Layered Cocktail' Approach Likely)
November 21, 2005... About half of the estimated 18 million diabetics in the U.S. either have or will develop nephropathy, a potentially catastrophic condition that is the most common cause of chronic kidney failure and end-stage renal disease. With only...

10 biggest U.S. gainers for the week.
November 21, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Viragen 54.76 Neurocrine Biosci 3.62 Biomira 36.00 Celgene 2.85 Avant Immuno 26.71 New...

10 biggest U.S. losers for the week.
November 21, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Large Scale -39.5 Martek Bio -3.37 VioQuest -33.3 OSI Pharma -2.55 Immune Resp -29.6 Onyx...

Collaborations between biotechnology companies and government/nonprofit institutions: Sept. 1-Nov. 16, 2005.
November 21, 2005... Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: Sept. 1-Nov. 16, 2005 Company * University/ Type Of (Country; Symbol) Nonprofit (@) Agreement Affibody...

BioWorld stock report for public biotechnology companies.
November 21, 2005... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 11/11 11/18 WK YTD (000) Aastrom Biosci ASTM ...

CCR2 interest increasing after potential $803m deal for Incyte.
November 28, 2005... "It's been a busy morning," said Markus Cappel, vice president of corporate and business development for ChemoCentryx Inc., which found itself the target of phone queries last Monday as a result of the potential $803 million research and...

Biotech collaborations and other actions in agriculture and animals: Nov. 23, 2004-Nov. 22, 2005.
November 28, 2005... Biotech Collaborations And Other Actions In Agriculture And Animals: Nov. 23, 2004-Nov. 22, 2005 Biotech Co. * Agbiotech Type/Product (Country; Partner/Institution Area Symbol) AgraQuest U.S....

BioWorld stock report for public biotechnology companies.
November 28, 2005... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 11/18 11/23 WK YTD Aastrom Biosci ASTM 2.16 2.07 -4.17% ...